Skip to main content

Table 3 Results of the Centre of Disease Control and Prevention antinuclear antibodies reference sera

From: Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus

Sample

SmD3

SmD1

RNP/Sm ELISA

SmD ELISA

Autoantibody [24, 35]

1

10.3

115.6

3.0

1.9

dsDNA, ssDNA, histone, (weak) Sm

2

1.4

11.4

0.3

0.3

(weak) SS-A, SS-B

3

1.9

18.1

7.3

1.6

(weak) Sm, SS-A, SS-B

4

2.5

19.6

7.5

0.4

U1 RNP

5

>100.0

>200

7.8

6.0

Histone, Sm

6

3.1

14.5

0.5

0.3

Nucleolar

7

0.0

7.7

0.2

0.3

SS-A

8

0.1

6

0.2

0.3

Centromere

9

1.7

18

0.2

0.3

Scl-70

10

0.5

3.1

0.1

0.1

Jo-1

11

0.6

11.9

0.3

0.4

PM/Scl complex

  1. Bold data indicate positive test result in the respective test. PM/Scl complex = polymyositis/scleroderma overlap complex